Stockreport

Piper Sandler Keeps an Overweight Rating on ImmunityBio, Inc. (IBRX) [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF ImmunityBio, Inc. (NASDAQ: IBRX is among the 12 Best Performing Stocks in February Piper Sandler Keeps an Overweight Rating on ImmunityBio, Inc. (IBRX) On March 4, [Read more]